Related Experiment Video

Updated: Jul 4, 2026

Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector
08:10

Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector

Published on: November 28, 2018

A combination vaccine against measles, mumps, rubella and varicella

Markus Knuf1, Jörg Faber, Immanuel Barth

  • 1Pediatric University Hospital, Johannes Gutenberg University, Mainz, Germany. knuf@kinder.klinik.uni-mainz.de

Drugs of Today (Barcelona, Spain : 1998)
|June 10, 2008
PubMed

Insights

A new measles, mumps, rubella, and varicella (MMRV) vaccine offers convenient protection. Clinical studies show it is as effective and well-tolerated as separate vaccines, with similar fever rates.

Area of Science:

  • Immunology
  • Vaccinology
  • Pediatrics

Background:

  • Measles, mumps, rubella, and varicella are common childhood infectious diseases.
  • Combination vaccines simplify immunization schedules and improve coverage.
  • Live, attenuated vaccines are a cornerstone of pediatric infectious disease prevention.

Purpose of the Study:

  • To review the development and clinical performance of a new combination measles, mumps, rubella, and varicella (MMRV) vaccine.
  • To evaluate the immunogenicity and tolerability of the MMRV vaccine compared to separate administration of MMR and varicella vaccines.
  • To highlight the benefits of the MMRV vaccine for public health initiatives.

Main Methods:

  • Review of published clinical studies on the GlaxoSmithKline Biologicals MMRV vaccine.
  • Analysis of seroconversion rates and antibody titers post-vaccination.
  • Assessment of clinical safety profiles, including injection-site reactions and general tolerability.

Main Results:

  • The MMRV vaccine demonstrated comparable seroconversion rates and antibody titers to concomitant MMR and varicella vaccines.
  • The safety profile of the MMRV vaccine was similar to its component vaccines.
  • A slightly higher incidence of low-grade fever was observed after the first MMRV dose, but not the second.

Conclusions:

  • The new MMRV vaccine provides effective and safe immunization against four diseases with a single injection.
  • Its introduction can enhance varicella vaccination rates and overall vaccine coverage.
  • The MMRV vaccine offers significant advantages for children, parents, and healthcare providers.

More Related Videos

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Chickenpox01:20

Chickenpox

Chickenpox is an acute, highly contagious disease caused by the varicella-zoster virus (VZV), a double-stranded DNA virus belonging to the Herpesviridae family. Its transmission occurs primarily through the inhalation of respiratory droplets or direct contact with vesicular fluid from skin lesions. The incubation period typically ranges from 10 to 21 days, during which the virus replicates and disseminates through sequential phases within the host. Although generally self-limiting in children,...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
Cross-reactivity00:42

Cross-reactivity

Overview